Handwriting boosts brain connectivity and learning

As digital devices progressively replace pen and paper, taking notes by hand is becoming increasingly uncommon in schools and universities.

Injectable Ketamine Shows Promise in Treatment-Resistant Depression

Twice-weekly subcutaneous ketamine helped alleviate symptoms of treatment-resistant depression, according to the phase III KADS study. Among those who received at least one flexible treatment

July 15, 2023

FDA commissioner: Health systems have to ‘step up’ on AI regulation or will ‘end up holding the bag’

WELLESLEY, Mass. — Amid heated discussions on how artificial intelligence should be regulated and who should be involved in health care AI governance, the U.S.

September 11, 2024

Secarna Pharmaceuticals will present data at 6th Inflammasome Therapeutics Summit demonstrating the potential of ASOs to target the expression of NLRP3 – Biotech Investments

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Conference Secarna Pharmaceuticals will present data at 6th Inflammasome Therapeutics Summit demonstrating the potential of

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.